XML 139 R43.htm IDEA: XBRL DOCUMENT v3.25.1
Fair value measurements (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Change in Fair Value
As of December 31, 2024, the Company has no remaining warrants outstanding.
Public Warrants
Private Placement Warrants
Total Warrant liability
Balance, December 31, 2022
$12,960 $7,055 $20,015 
Change in fair value18,439 15,663 34,102 
Balance, December 31, 2023
$31,399 $22,718 $54,117 
Change in fair value78,969 32,294 111,263 
Reclassification to equity
(110,368)(55,012)(165,380)
Balance, December 31, 2024
$— $— $— 
Restricted sponsor shares
Price adjustment shares
Total
Balance, December 31, 2022
$17,532 $26,184 $43,716 
Change in fair value of restricted sponsor shares and price adjustment shares29,715 55,531 85,246 
Balance, December 31, 2023
$47,247 $81,715 $128,962 
Change in fair value of restricted sponsor shares and price adjustment shares65,889 173,051 238,940 
Reclassification to equity
(113,136)(254,766)(367,902)
Balance, December 31, 2024
$— $— $— 
Schedule of Level 3 Fair Value Measurement Inputs
The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:
 December 31, 2024
December 31, 2023
Number of private placement warrants9,666,667
Exercise price$11.5
Share price$8.66
Expiration term (in years)2.66
Volatility 51.9%
Risk-free Rate4.10%
Dividend yield0%
The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates:
September 13, 2024December 31, 2023
Restricted sponsor sharesPrice adjustment sharesRestricted sponsor sharesPrice adjustment shares
Number of shares1,500,0005,000,0007,500,00015,000,000
Share price
$30.0
$17.5
$12.5-$30.0
$12.5-$17.5
Remaining exercise period3.961.964.662.66
Share value
$12.52
$15.97
$3.62-$7.17
$4.47-$6.31